LEMD2 and breast carcinoma: Given the Lem-D transcripts, Ankle2, TMPO, Emerin, and Lemd2, were overexpressed in breast cancer patient samples and overexpression largely associated with poorer patient outcomes, we next investigated whether the Lem-D proteins were similarly overexpressed in TNBC cell lines.